GFAP and Alzheimer disease: Although GFAP labeling in the DMH was correlated with weight gain in all groups, GFAP labeling in the ARC, VMH, and PVN, and GFAP expression in the whole hypothalamus was positively correlated with metabolic outcomes such as weight gain in AD females only.